TSA Medical Marijuana Policy Unchanged Despite Viral Claims
- MEDICAL MARIJUANA
- June 2, 2026
Indiana may soon join its neighboring states in legalizing medical marijuana, as incoming Governor Mike Braun declares it’s “probably time” for the reform. A recent Ball State University poll reveals overwhelming support, with nearly 87% of Hoosiers favoring medical cannabis legalization. Braun, currently a U.S. Senator, has consistently voiced support for medical marijuana, citing “free
READ MOREA groundbreaking clinical trial has revealed that medicinal cannabis could be a life-altering treatment for individuals suffering from Tourette syndrome. The study, published in the New England Journal of Medicine: Evidence, demonstrated a significant reduction in motor and vocal tics in just six weeks. Led by Dr. Philip Mosley and co-funded by the University of
READ MOREThe Drug Enforcement Administration (DEA) has announced a significant delay in its decision on marijuana rescheduling, pushing the timeline beyond the upcoming presidential election. According to a recent Forbes report, the DEA has scheduled a hearing for December 2 to discuss the Biden administration’s proposal to reclassify marijuana under federal drug laws. This move effectively
READ MOREA groundbreaking review titled Medical Cannabis & Epilepsy has been released by Maple Tree Consultants, providing a comprehensive analysis of the role of cannabis-based medicines in managing epilepsy. This publication, co-authored by experts including Professor Mike Barnes and Hannah Deacon, compiles findings from nearly 100 clinical trials and observational studies, making it an invaluable resource
READ MORERecent data from Florida’s Office of Medical Marijuana Use reveals a significant slowdown in the state’s medical cannabis market. Patient growth has decelerated to a record low of 2.7% annually, down from 8.4% in late May. Despite an increase in dispensaries, the market is facing challenges with slowing revenue growth and increasing competition. Interestingly, unit
READ MOREA groundbreaking study published in Progress in Neuropsychopharmacology & Biological Psychiatry reveals that cannabidiol (CBD) may effectively reduce fever and inflammation. Researchers at the University of São Paulo found that CBD lowered fever in mice by altering biological pathways related to stress and inflammation responses. The study, led by Professor Luiz Guilherme S. Branco, demonstrated
READ MOREAs the use of medicinal cannabis grows in Australia, healthcare professionals are calling for increased awareness and monitoring of potential side effects. Recent reports from doctors indicate a rise in psychosis cases among patients prescribed medicinal cannabis, prompting a closer look at prescription practices and patient education. While these concerns highlight the need for caution,
READ MOREHealth Canada has widened its recall of cannabis oils and softgels, now affecting 14 lots of products from multiple brands. The recall, which began in June, has expanded to include over 17,000 units sold across six provinces and territories between December 2022 and July 2024. The agency’s inspection revealed significant quantities of intoxicating cannabinoids HHC
READ MOREA groundbreaking study led by researchers at the Philadelphia College of Osteopathic Medicine has found that medical marijuana users experience significant short-term improvements in their quality of life. The research, published in the Journal of Cannabis Research, followed nearly 400 adults new to medical marijuana use in Pennsylvania. Participants reported substantial gains across various aspects
READ MORE